Literature DB >> 7839094

Distinct profiles of gastritis in dyspepsia subgroups. Their different clinical responses to gastritis healing after Helicobacter pylori eradication.

E Trespi1, F Broglia, L Villani, O Luinetti, R Fiocca, E Solcia.   

Abstract

BACKGROUND: A contribution of Helicobacter pylori gastritis to the pathogenesis of non-ulcer dyspepsia (NUD) remains uncertain.
METHODS: Administration of an appropriate clinical questionnaire followed by endoscopy allowed us to select, among 139 outpatients with dyspepsia, 87 non-ulcer dyspepsia patients with more severe and group-distinctive symptoms, 35 of whom were classified as having ulcer-like (ULD). 38 as dysmotility-like (DLD), and 14 as reflux-like dyspepsia (RLD). Biopsy specimens were evaluated for H. pylori gastritis in accordance with the Sydney system. The 70 H. pylori-positive cases were treated with omeprazole, 20 mg twice daily, and amoxycillin, 1 g three times daily for 2 weeks.
RESULTS: Higher rates of H. pylori colonization were found histologically in the gastric mucosa of ULD (91%) and RLD (86%) than in that of DLD (68%) or asymptomatic (42%) patients. ULD differed from RLD patients in their higher score of antritis activity. Three and 6 months after H. pylori eradication ULD (but not DLD) showed significant regression of dypspetic symptoms scores.
CONCLUSIONS: It seems likely that H. pylori gastritis, with special reference to active antritis, is among causative factors of ULD. Its role in the pathogenesis of RLD and DLD needs further investigation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7839094     DOI: 10.3109/00365529409094858

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  14 in total

1.  Effect of Helicobacter pylori infection on gastric emptying and gastrointestinal hormones in dyspeptic and healthy subjects.

Authors:  M Chiloiro; F Russo; G Riezzo; C Leoci; C Clemente; C Messa; A Di Leo
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

2.  Eradication of helicobacter pylori to prevent gastroduodenal diseases: hitting more than one bird with the same stone.

Authors:  Yi-Chia Lee; Jyh-Ming Liou; Ming-Shiang Wu; Chun-Ying Wu; Jaw-Town Lin
Journal:  Therap Adv Gastroenterol       Date:  2008-09       Impact factor: 4.409

Review 3.  How should Helicobacter pylori negative patients be managed?

Authors:  V Stanghellini; C Tosetti; R De Giorgio; G Barbara; B Salvioli; R Corinaldesi
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

Review 4.  Helicobacter pylori in gastro-oesophageal reflux disease: causal agent, independent or protective factor?

Authors:  J Labenz; P Malfertheiner
Journal:  Gut       Date:  1997-09       Impact factor: 23.059

5.  Relation between Helicobacter pylori infection and gastrointestinal symptoms and syndromes.

Authors:  S Rosenstock; L Kay; C Rosenstock; L P Andersen; O Bonnevie; T Jørgensen
Journal:  Gut       Date:  1997-08       Impact factor: 23.059

6.  Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group.

Authors:  N J Talley; J Janssens; K Lauritsen; I Rácz; E Bolling-Sternevald
Journal:  BMJ       Date:  1999-03-27

Review 7.  Efficacy of Rebamipide in Organic and Functional Dyspepsia: A Systematic Review and Meta-Analysis.

Authors:  Mohamed Hasif Jaafar; Sher Zaman Safi; Maw-Pin Tan; Sanjay Rampal; Sanjiv Mahadeva
Journal:  Dig Dis Sci       Date:  2017-12-01       Impact factor: 3.199

Review 8.  Management of dyspepsia in general practice. A critical assessment.

Authors:  C Tosetti; V Stanghellini
Journal:  Pharmacoeconomics       Date:  1998       Impact factor: 4.981

Review 9.  A risk-benefit assessment of drugs used in the eradication of Helicobacter pylori infection.

Authors:  A Hackelsberger; P Malfertheiner
Journal:  Drug Saf       Date:  1996-07       Impact factor: 5.606

10.  Combined analysis of the ORCHID and OCAY studies: does eradication of Helicobacter pylori lead to sustained improvement in functional dyspepsia symptoms?

Authors:  S J O Veldhuyzen van Zanten; N J Talley; A L Blum; E Bolling-Sternevald; M Sundin; O Junghard
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.